FDA Inspection 850573 — Impladent Ltd.

Impladent Ltd. — FEI 2431866

The FDA completed an inspection of Impladent Ltd. on September 26, 2013 in Jamaica, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 26, 2013
Fiscal Year
2013
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Jamaica, NY (United States)

Additional Details

Sponsor, Contract Research Organization